Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-082442
Filing Date
2025-06-05
Accepted
2025-06-05 16:53:31
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1436
  Complete submission text file 0000950170-25-082442.txt   2897
Mailing Address BAKER BROS. ADVISORS LP 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address
BAKER JULIAN (Reporting) CIK: 0001087939 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38311 | Film No.: 251027847

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8547
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)